Compare MRKR & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRKR | UPLD |
|---|---|---|
| Founded | 1999 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.5M | 17.3M |
| IPO Year | 2010 | 2014 |
| Metric | MRKR | UPLD |
|---|---|---|
| Price | $1.13 | $4.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $10.00 | $3.75 |
| AVG Volume (30 Days) | ★ 58.6K | 16.4K |
| Earning Date | 05-14-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.61 | ★ 63.38 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $74,767,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $936.27 | $1.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.95 |
| 52 Week Low | $0.81 | $0.50 |
| 52 Week High | $2.46 | $6.65 |
| Indicator | MRKR | UPLD |
|---|---|---|
| Relative Strength Index (RSI) | 35.82 | 51.90 |
| Support Level | $0.96 | $0.62 |
| Resistance Level | $1.52 | $5.65 |
| Average True Range (ATR) | 0.07 | 0.39 |
| MACD | -0.02 | -0.16 |
| Stochastic Oscillator | 27.91 | 25.70 |
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.